By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Pulse Biosciences, Inc.

Pulse Biosciences, Inc. (PLSE)

NASDAQ Currency in USD
$15.10
+$0.33
+2.23%
Last Update: 11 Sept 2025, 20:00
$1.02B
Market Cap
-15.98
P/E Ratio (TTM)
Forward Dividend Yield
$13.77 - $25.00
52 Week Range

PLSE Stock Price Chart

Explore Pulse Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze PLSE price movements and trends.

PLSE Company Profile

Discover essential business fundamentals and corporate details for Pulse Biosciences, Inc. (PLSE) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

18 May 2016

Employees

75.00

CEO

Paul Arthur LaViolette

Description

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

PLSE Financial Timeline

Browse a chronological timeline of Pulse Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 May 2026

Upcoming earnings on 29 Oct 2025

EPS estimate is -$0.31, while revenue estimate is $500.00K.

Earnings released on 12 Aug 2025

EPS came in at -$0.28 falling short of the estimated -$0.26 by -7.69%.

Earnings released on 8 May 2025

EPS came in at -$0.17 .

Earnings released on 27 Mar 2025

EPS came in at -$0.17 surpassing the estimated -$0.24 by +29.17%, while revenue for the quarter reached $1.66M .

Earnings released on 30 Oct 2024

EPS came in at -$0.16 surpassing the estimated -$0.24 by +33.33%.

Earnings released on 19 Aug 2024

EPS came in at -$0.20 surpassing the estimated -$0.24 by +17.05%.

Earnings released on 7 May 2024

EPS came in at -$0.14 surpassing the estimated -$0.24 by +41.67%.

Earnings released on 28 Mar 2024

EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%, while revenue for the quarter reached $1.74M .

Earnings released on 13 Nov 2023

EPS came in at -$0.15 surpassing the estimated -$0.24 by +37.50%.

Earnings released on 10 Aug 2023

EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%.

Earnings released on 11 May 2023

EPS came in at -$0.23 falling short of the estimated -$0.22 by -4.55%.

Earnings released on 30 Mar 2023

EPS came in at -$0.22 surpassing the estimated -$0.24 by +8.33%, while revenue for the quarter reached -$9.00K , missing expectations by -104.50%.

Earnings released on 10 Nov 2022

EPS came in at -$0.46 falling short of the estimated -$0.45 by -2.22%.

Earnings released on 10 Aug 2022

EPS came in at -$0.37 matching the estimated -$0.37, while revenue for the quarter reached $265.00K , missing expectations by -39.73%.

Earnings released on 11 May 2022

EPS came in at -$0.48 surpassing the estimated -$0.51 by +5.88%, while revenue for the quarter reached $444.00K , missing expectations by -37.93%.

Earnings released on 31 Mar 2022

EPS came in at -$0.39 surpassing the estimated -$0.50 by +22.00%, while revenue for the quarter reached $844.00K , missing expectations by -3.21%.

Earnings released on 15 Nov 2021

EPS came in at -$0.42 surpassing the estimated -$0.54 by +22.22%, while revenue for the quarter reached $574.00K , missing expectations by -33.26%.

Earnings released on 9 Aug 2021

EPS came in at -$0.48 surpassing the estimated -$0.79 by +39.24%.

Earnings released on 10 May 2021

EPS came in at -$0.43 surpassing the estimated -$0.52 by +17.31%.

Earnings released on 22 Feb 2021

EPS came in at -$0.54 falling short of the estimated -$0.45 by -20.00%.

Earnings released on 9 Nov 2020

EPS came in at -$0.51 falling short of the estimated -$0.44 by -15.91%.

PLSE Stock Performance

Access detailed PLSE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run